HC Deb 25 February 2004 vol 418 cc494-5W
Mr. Burstow

To ask the Secretary of State for Health what the timetable is for implementing the Medicines and Healthcare Products Regulatory Agency awareness campaign for nurses about the recent name changes to UK medicines; and if he will make a statement. [154587]

Ms Rosie Winterton

The names of some medicinal substances are changing in the United Kingdom so that British approved names reflect recommended International non-proprietary names, where these currently differ. This action is being taken on the advice of the Medicines Commission and with the support of a wide range of interest groups. It will reduce the risk of confusion on the part of both healthcare professionals and patients arising from the availability on the market of some medicines using two different names.

The name changes were published in the 2003 edition of the British Pharmacopoeia and became effective on 1 December 2003. From this date, licence holders for medicinal products using the old names were given 12 months to apply to the Medicines and Healthcare Products Regulatory Agency to update their licences to use the new names.

We are committed to ensuring that all those who are responsible for prescribing, dispensing and administering medicines receive full information about the name changes and expect shortly to be in a position to issue detailed guidance and advice to healthcare professionals, including nurses.